Cubist Systematic Strategies, LLC Harvard Bioscience Inc Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.77 - $4.63 $39,176 - $65,482
14,143 New
14,143 $40,000
Q2 2023

Aug 14, 2023
BUY
$4.19 - $6.16 $138,772 - $204,019
33,120 New
33,120 $181,000
Q2 2022

Aug 15, 2022
BUY
$3.28 - $6.42 $75,249 - $147,287
22,942 New
22,942 $83,000
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $92,722 - $112,515
-13,284 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $72,264 - $111,585
13,284 New
13,284 $111,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email